An overview of contact dermatitis: occupational factors and preventive strategies
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20242901Keywords:
Contact dermatitis, Occupational skin disorders, Preventive strategiesAbstract
Contact dermatitis, encompassing both acute and chronic skin inflammation, arises from exposure to chemical or physical agents. This condition, which includes irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD), represents 95% of occupational skin disorders. ICD, accounting for 80% of cases, results from a direct cytotoxic effect on skin cells due to irritants such as abrasives and cleaning agents. It manifests as burning, stinging, and various degrees of skin damage. Chronic ICD stems from repeated exposure to irritants like solvents, while acute cases can result from single exposures or ultraviolet-induced reactions. In contrast, ACD, which constitutes 20% of cases, develops due to an allergic reaction to specific substances after sensitization. Individuals in certain professions, including hairdressers and healthcare workers, are particularly at risk. Preventive strategies include educational programs, protective measures like barrier creams and gloves, and regulatory controls. Emerging treatments focus on antioxidants, chelators, and specialized formulations to manage symptoms and improve occupational health.
Metrics
References
Bains SN, Nash P, Fonacier L. Irritant Contact Dermatitis. Clin Rev Allergy Immunol. 2019;56(1):99-109.
Hadžavdić SL, Pustišek N, Žužul K, Švigir A. Contact allergy: an update. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2018;153(3):419-28.
Martin SF, Rustemeyer T, Thyssen JP. Recent advances in understanding and managing contact dermatitis. F1000 Res. 2018;7.
Brites GS, Ferreira I, Sebastião AI, et al. Allergic contact dermatitis: From pathophysiology to development of new preventive strategies. Pharmacol Res. 2020;162:105282.
Kimber I, Dearman RJ. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis. 2002;46(1):1-5.
Thyssen JP, Linneberg A, Menné T, Johansen JD. The epidemiology of contact allergy in the general population – prevalence and main findings. Contact Dermatitis. 2007;57(5):287-99.
McSweeney SM, White IR, Kimber I, McFadden JP, Tziotzios C. Contact allergy across the human lifespan. J Allergy Clin Immunol. 2020;145(5):1352-4.
Mowad CM, Anderson B, Scheinman P, Pootongkam S, Nedorost S, Brod B. Allergic contact dermatitis: Patient management and education. J Am Acad Dermatol. 2016;74(6):1043-54.
Lee HY, Stieger M, Yawalkar N, Kakeda M. Cytokines and chemokines in irritant contact dermatitis. Mediators Inflammation. 2013;2013(1):916497.
Lurati AR. Occupational risk assessment and irritant contact dermatitis. Workplace Health Safety. 2015;63(2):81-7.
Frosch PJ, John SM. Clinical aspects of irritant contact dermatitis. Springer. 2011.
Mahler V, Diepgen T, Skudlik C, Becker D, Dickel H, Fartasch M, et al; Work Group "Assessment of allergens in occupational disease (BK) 5101" of the Study Group Occupational and Environmental Dermatology (ABD); German Contact Dermatitis Group (DKG) of the German Dermatological Society. Psoriasis predisposition and occupational triggering factors in the appraisal of occupational medical expertises. J Dtsch Dermatol Ges. 2014;12(6):519-29.
Thielitz A, John SM. Occupational Contact Dermatitis. In: Johansen JD, Lepoittevin J-P, Thyssen JP, eds. Quick Guide to Contact Dermatitis. Berlin, Heidelberg: Springer Berlin Heidelberg. 2016;103-14.
Apfelbacher CJ, Funke U, Radulescu M, Diepgen TL. Determinants of current hand eczema: results from case–control studies nested in the PACO follow-up study (PACO II). Contact Dermatitis. 2010;62(6):363-70.
Skudlik C, Weisshaar E, Scheidt R, Elsner P, Wulfhorst B, Schönfeld M, et al; ROQ Study Group. First results from the multicentre study rehabilitation of occupational skin diseases--optimization and quality assurance of inpatient management (ROQ). Contact Dermatitis. 2012;66(3):140-7.
Ibler KS, Jemec GB, Flyvholm MA, Diepgen TL, Jensen A, Agner T. Hand eczema: prevalence and risk factors of hand eczema in a population of 2274 healthcare workers. Contact Dermatitis. 2012;67(4):200-7.
Bauer A, Rönsch H, Elsner P, Dittmar D, Bennett C, Schuttelaar MLA, et al. Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev. 2018;4(4):CD004414.
Rosmaninho I, Moreira A, Silva JP. Dermatite de contacto: revisão da literatura. Revista portuguesa de imunoalergologia. 2016;24(4):197-209.
Nicholson PJ. Occupational contact dermatitis: known knowns and known unknowns. Clin Dermatol. 2011;29(3):325-30.
Holness DL, Beaton D, Harniman E, DeKoven J, Skotnicki S, Nixon R, et al. Hand and upper extremity function in workers with hand dermatitis. Dermatitis. 2013;24(3):131-6.
Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, et al. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 2012;69(5):763-81.
Wöhrl S, Kriechbaumer N, Hemmer W, Focke M, Brannath W, Götz M, et al. A cream containing the chelator DTPA (diethylenetriaminepenta-acetic acid) can prevent contact allergic reactions to metals. Contact Dermatitis. 2001;44(4):224-8.
Mostosi C, Simonart T. Effectiveness of Barrier Creams against Irritant Contact Dermatitis. Dermatology. 2016;232(3):353-62.
Bourke J, Coulson I, English J. Guidelines for the management of contact dermatitis: an update. Br J Dermatol. 2009;160(5):946-54.
de Waard-van der Spek FB, Andersen KE, Darsow U, Mortz CG, Orton D, Worm M, et al. Allergic contact dermatitis in children: which factors are relevant? (review of the literature). Pediatr Allergy Immunol. 2013;24(4):321-9.
Miles J, Mudgal K, Patel S, Punjabi S. Contact allergy to commonly prescribed emollients. BMJ. 2017;357.
Martin SF. New concepts in cutaneous allergy. Contact Dermatitis. 2015;72(1):2-10.
Van Ketel W, Bruynzeel D. Chelating effect of EDTA on nickel. Contact Dermatitis. 1984;11(5):311-4.
Tina L, Magnus B, Malin E, Marléne I, Cecilia S, Erik Z, et al. Can the Reactivity to Chromate Be Changed in Patch Testing Using a Barrier Cream? Dermatitis. 2020;31(6):373-7.